The relationship of sleep disturbances and fatigue in multiple sclerosis

Archives of Neurology

Volumn 61, Issue 4, 2004, Pages 525-528

  Attarian, Hrayr P ^a   Brown, Kelly M ^c   Duntley, Stephen P ^b   Carter, Jewell D ^b   Cross, Anne H ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST JOHN S MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIMETRY; ADULT; ARTICLE; BIOLOGICAL RHYTHM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; EPWORTH SLEEPINESS SCALE; EXPERIENCE; FATIGUE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER; SLEEP PATTERN; SLEEP WAKING CYCLE; CASE CONTROL STUDY; CIRCADIAN RHYTHM SLEEP DISORDER; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS; SUPRACHIASMATIC NUCLEUS;

ADULT; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SLEEP DISORDERS, CIRCADIAN RHYTHM; STATISTICS; SUPRACHIASMATIC NUCLEUS;

EID: 2342524005     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.4.525     Document Type: Article

References (24)

1. Ibata Y, Okamura H, Tanaka M, et al. Functional morphology of the suprachiasmatic nucleus. Front Neuroendocrinol. 1999;20:241-268.
2. Stopa EG, Volicer L, Kuo-Leblanc V, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol. 1999;58:29-39.
3. Okawa M, Mishima K, Hishikawa Y, et al. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep. 1991;14:478-485.
4. Yesavage JA, Friedman L, Kraemer HC, et al. A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients. J Geriatr Psychiatry Neurol. 1998;11:7-10.
5. Reder AT, Antel JP. Clinical spectrum of multiple sclerosis. Neurol Clin. 1983;1:573-599.
6. Krupp LB, Coyle PK, Doscher C, et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology. 1995;45:1956-1961.
7. Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol. 1996;9:456-460.
8. Taphoorn MJ, van Someren E, Snoek FJ, et al. Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol. 1993;240:446-448.
9. Soorensen KV, Alslev T, Christensen SE, Jensen NB, Orskov H. CSF somatostatin in multiple sclerosis: reversible loss of diurnal oscillation in relapses. Neurology. 1987;37:1050-1053.
10. Ferini-Strambi L, Filippi M, Martinelli V, et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci. 1994;125:194-197.
11. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol. 1994;34:320-323.
12. Iriarte J, Katsamakis G, de Castro P. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler. 1999;5:10-16.
13. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(suppl 1):S79-S83.
14. Egg R, Hoegl B, Glatzl S, Beer R, Berger T. Autonomic instability, as measured by pupillary unrest, is not associated with multiple sclerosis fatigue severity. Mult Scler. 2002;8:256-260.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33:1444-1452.
16. Lasa L, Ayuso-Mateos JL, Vazquez-Barquero JL, Diez-Manrique FJ, Dowrick CF. The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis. J Affect Disord. 2000;57:261-265.
17. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540-545.
18. American Sleep Disorders Association. Practice parameters for the use of actigraphy in the clinical assessment of steep disorders. Sleep. 1995;18:285-287.
19. Sadeh A, Hauri PJ, Kripke DF, Lavie P. The role of actigraphyin the evaluation of sleep disorders. Sleep. 1995;18:288-302, 320.
20. American Sleep Disorders Association. International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, Minn: American Sleep Disorders Association; 1997.
21. Iseki K, Mezaki T, Oka Y, et al. Hypersomnia in MS. Neurology. 2002;59:2006-2007.
22. Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol. 1992;49:641-643.
23. van der Werf SP, Jongen PJ, Lycklama A, et al. Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability. J Neurol Sci. 1998;160:164-170.
24. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth Sleepiness Scale: failure of the MSLT as a gold standard. J Sleep Res. 2000;9:5-11.